---
title: Article 10 — General Obligations of Manufacturers
description: EU MDR 2017/745 Article 10 sets out the general obligations of medical device manufacturers, including requirements for quality management systems, clinical evaluation, post-market surveillance and more.
regulation: EU MDR 2017/745
article: Article 10
---

# Article 10 — General Obligations of Manufacturers

**Source**: [EU MDR 2017/745 Article 10](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745) | OJ L 117, 5.5.2017

## Core Requirements

Before placing a device on the market or putting it into service, manufacturers shall ensure that the device has been designed and manufactured in accordance with this Regulation.

### 10.1 — Quality Management System (QMS)

Manufacturers shall establish, document, implement, maintain, update and continuously improve a quality management system covering at least:

- A regulatory compliance strategy, including conformity assessment procedures and device change management
- Identification of applicable GSPRs and exploration of options to meet those requirements
- Responsibilities for design and development of devices
- Management of production and service provision
- Risk management (see [Annex I GSPR](./annex-i-gspr))
- Clinical evaluation (see [Annex XIV](./annex-xiv-clinical-evaluation)), including PMCF
- Labelling and packaging
- Post-market surveillance (PMS), including PMCF (see [Annex III](./annex-iii-pms))
- Communication with competent authorities, notified bodies, economic operators, customers and/or other relevant parties
- Processes for information transfer and coordination between economic operators
- Reporting of serious incidents and field safety corrective actions
- Corrective and preventive actions and verification of their effectiveness

### 10.2 — Technical Documentation

Manufacturers shall draw up, keep up to date and make available technical documentation in accordance with [Annex II](./annex-ii-technical-documentation) and [Annex III](./annex-iii-pms).

### 10.3 — Conformity Assessment

Manufacturers shall subject their devices to the applicable conformity assessment procedure as set out in [Article 52](./art-52-conformity-assessment).

### 10.4 — EU Declaration of Conformity

Manufacturers shall draw up an EU declaration of conformity in accordance with [Article 19](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745) and affix the CE marking to the device (see [Article 20](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745)).

### 10.9 — Authorised Representative

Manufacturers established outside the EU shall designate a single authorised representative (AR) within the EU.

### 10.12 — Person Responsible for Regulatory Compliance (PRRC)

Manufacturers shall ensure that they have at least one person responsible for regulatory compliance (PRRC) with the requisite expertise in the field of medical devices.

**PRRC Responsibilities**:
- Ensure that the conformity of the devices is appropriately checked before release
- Ensure that the technical documentation and the EU declaration of conformity are drawn up and kept up to date
- Ensure that post-market surveillance obligations are fulfilled
- Ensure that the reporting obligations for serious incidents and field safety corrective actions are fulfilled
- Ensure that, in the context of investigations, the necessary support is provided to competent authorities

## Related Articles

- [Article 52 — Conformity Assessment Procedures](./art-52-conformity-assessment)
- [Annex I — GSPR](./annex-i-gspr)
- [Annex II — Technical Documentation](./annex-ii-technical-documentation)
- [Annex XIV — Clinical Evaluation](./annex-xiv-clinical-evaluation)

## Official Sources

- [EUR-Lex: EU MDR 2017/745 full text](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745)
- [Data layer source file](https://github.com/RASAAS/docmcp-knowledge/tree/main/eu_mdr/regulations/mdr-2017-745.json)
